![NATCO Pharma Limited logo](/logos/NATCOPHARM.NS.webp)
NATCO Pharma Limited
NSE:NATCOPHARM.NS
Overview | Financials
Company Name | NATCO Pharma Limited |
Symbol | NATCOPHARM.NS |
Currency | INR |
Price | 1,559.9 |
Market Cap | 279,393,689,000 |
Dividend Yield | 0.96% |
52-week-range | 724.2 - 1,598 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Rajeev Nannapaneni |
Website | https://www.natcopharma.co.in |
An error occurred while fetching data.
About NATCO Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD